s6y
Company name or ticker
Search
Lakefront Biotherapeutics NV
6-K
Current report (foreign issuer)
Filed
Tuesday, December 13, 2022
Period
Dec 13, 2022
Accession number
0001171843-22-008012
Documents
Current report (foreign issuer)
6-K
99.1
Press Release
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header